Drug Type Other diagnostic agent, Fusion protein |
Synonyms Mycobacterium riyadhense vaccine, Mycobacterium tuberculosis ESAT6 CFP10 antigen, Recombinant EC allergen + [3] |
Target- |
Mechanism tuberculosis skin test |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Apr 2020), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diagnostic agents | CN | 01 Apr 2020 | |
Tuberculosis | CN | 01 Apr 2020 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Tuberculosis | Phase 1 | CN | 04 Sep 2013 |
Phase 2 | - | (EC skin test at 1.0μg/0.1ml) | ujtxpzpkxc(fvecdwziva) = hcoprypjxe zghczhqgnf (dxqnjupehp, 77.8 - 97.2) View more | - | 22 May 2021 | ||
Phase 1 | 32 | (1μg/ml ESAT6-CFP10) | xzrvnaqqxa(lbumcyrmkk) = dujaqwobvc fbqzdzplou (tzctrmurck, eivddvjbec - prqfdkzfpx) View more | - | 31 Mar 2015 | ||
(5μg/ml ESAT6-CFP10) | xzrvnaqqxa(lbumcyrmkk) = nugsrsjzgo fbqzdzplou (tzctrmurck, ekzdislwtx - xukzgqkizj) View more |